Alvaro Mejia
About Alvaro Mejia
Alvaro Mejia is the General Manager at Bristol-Myers Squibb in Washington, D.C., with over 9 years of experience in the pharmaceutical industry and a background in operations and analytics.
Title at Bristol-Myers Squibb
Alvaro Mejia currently serves as the General Manager at Bristol-Myers Squibb. He is based in Washington, District of Columbia, United States. As General Manager, Alvaro is responsible for overseeing business operations, ensuring organizational efficiency, and implementing strategic initiatives within the company. He has been with Bristol-Myers Squibb since March 2014, marking over nine years of dedicated service in a senior leadership role.
Experience in the Pharmaceutical Industry
Alvaro Mejia has extensive experience in the pharmaceutical industry, particularly in managerial roles. His tenure at Bristol-Myers Squibb exceeds nine years, during which he has taken on significant responsibilities as General Manager. His role involves managing diverse teams, driving operational success, and aligning business strategies with company goals. His long-term involvement and leadership have contributed to his deep understanding of the pharmaceutical sector.
Previous Role at OlympiaWest Mortgage Group
Prior to his current position, Alvaro Mejia worked at OlympiaWest Mortgage Group as a Senior Analyst from 2005 to 2009. During his four years at the company, he developed a strong analytical background, conducting thorough financial analyses, risk assessments, and data-driven decision-making processes. His analytical skills from this role have been integral in his later managerial positions.
Operations Management at JDR Group
Alvaro Mejia served as the Operations Manager at JDR Group from 2005 to 2007. Over his two years in this role, he was responsible for overseeing day-to-day operations, streamlining processes, and improving operational efficiency. This position provided him with a solid foundation in operations management, which has been beneficial in his subsequent roles within the pharmaceutical industry.